.Attributes Medication, Posted online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Point of view requires inclusion of patients with MASLD as well as size of liver end results in cardio-- renal-- metabolic tests, when records propose mechanistically plausible perks and also clinical safety and security-- and describes factors for test layout and also governing commendation.